Clinical trials
Completed Phase 2 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 1 |
| Bioverativ, a Sanofi company | 1 |
| MedDay Pharmaceuticals SA | 1 |
| Nagoya University | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Northwestern University | 1 |
| Oregon Health and Science University | 1 |
| UCB Biopharma S.P.R.L. | 1 |
| UCB Biopharma SRL | 1 |
| University of Aarhus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 11 |
| Charcot-Marie-Tooth Disease | 1 |
| Demyelinating Diseases | 1 |
| Paraproteinemias | 1 |
| Peripheral Nervous System Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.